The Division of Workers’ Compensation’s Pharmacy and Therapeutics Committee is scheduled to discuss COVID-19 vaccines and changes to the Medical Treatment Utilization Schedule during its next meeting Jan. 20, according to an agenda posted online.
The meeting will be broadcast online and is scheduled to run from 12:30-2:30 p.m., according to the DWC.
Aside from the COVID-19 vaccine, committee members are expected to discuss anti-emetics and a formulary consolidation model that includes drug ingredient name changes to match FDA listings, and therapeutic category name changes f...
Comments